Edwards Lifesciences Q2 Profit Rises - Quick Facts

(RTTNews) - Edwards Lifesciences Corp. (EW) Thursday reported second-quarter profit of $94 million or $0.82 per share, up from $68 million or $0.57 per share in the same period last year.

Adjusted earnings for the quarter was $94.1 million or $0.82 per share. On average, 24 analysts polled by Thomson Reuters expected the company to earn $0.76 per share for the quarter. Analysts' estimates typically exclude special items.

Sales increased 7.3 percent to $517 million from $482.0 million last year. Analysts expected revenues of $514.68 million.

Looking ahead to the third quarter, the company targets earnings in the order of $0.63 to $0.67 per share, on revenues ranging between $475 million to $505 million. Analysts currently expect the company to earn $0.72 per share on third-quarter revenues of $493.50 million.

For the fiscal year 2013, the company continues to project earnings in the range of $3.00 to $3.10 per share and revenues in the order of $2.0 billion to $2.1 billion. Analysts currently expect the company to report full-year earnings of $3.06 per share on revenues of $2.05 billion.